Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state

被引:67
作者
Hensel, A [1 ]
Huter, V
Katinger, A
Raza, P
Strnistschie, C
Roesler, U
Brand, E
Lubitz, W
机构
[1] Univ Leipzig, Fac Vet, Inst Anim Hyg & Vet Publ Hlth, D-04103 Leipzig, Germany
[2] Univ Vienna, Bioctr, Inst Microbiol & Genet, Sect Microbiol & Biotechnol, A-1030 Vienna, Austria
[3] Univ Vet Med, Inst Bacteriol Mycol & Hyg, A-1210 Vienna, Austria
[4] EV AX Technol Vaccine Dev, D-82152 Munich, Germany
关键词
pig; bacterial ghosts; Actinobacillus pleuropneumoniae; vaccination; aerosol;
D O I
10.1016/S0264-410X(00)00107-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial ghosts are empty cell envelopes achieved by the expression of a cloned bacteriophage lysis gene and, unlike classical bacterins, suffer no denaturing steps during their production. These properties may lead to a superior presentation of surface antigens to the immune system. Currently available porcine Actinobacillus pleuropneumoniae vaccines afford only minimal protection by decreasing mortality but not morbidity. Pigs which survive infection can still be carriers of the pathogen, so a herd once infected remains infected. Carrier pigs harbour A. pleuropneumoniae in their nasal cavities, in their tonsils, or within lung lesions. A dose-defined nose-only aerosol infection model for pigs was used to study the immunogenic and protective potential of systemic immunization with ghosts made from A. pleuropneumoniae serotype 9 reference strain CVI 13261 against an homologous aerogenous challenge. Pigs were vaccinated twice intramuscularly with a dose of 5 x 10(9) CFU ghosts (GVPs) or formalin-inactivated A. pleuropneumoniae bacterins (BVPs). After 2 weeks vaccinated pigs and non-vaccinated placebo controls (PCs) were challenged with a dose of 10(9) CFU by aerosol. The protective efficacy of immunization was evaluated by clinical, bacteriological, serological and post-mortem examinations. Bronchoalveolar lavage in pigs was performed during the experiment to obtain lavage samples (BALF) for assessment of local antibodies. Isotype-specific antibody responses in serum and BALF were determined by ELISAs based on whole-cell antigen. Immunization with ghosts did not cause clinical side-effects. After aerosol challenge PCs developed fever and pleuropneumonia. GVPs or BVPs were found to be fully protected against clinical disease or lung lesions in both vaccination groups, whereas colonization of the respiratory tract with A. pleuropneumoniae was only prevented in GVPs, Specific immunoglobins against A, pleuropneumoniae were not detectable in BALF after immunization. A significant systemic increase of IgM, IgA, IgG(Fc'), or IgG(H + L) antibodies reactive with A. pleuropneumoniae was measured in GVPs and BVPs when compared to the non-exposed controls. BVPs reached higher titers of IgG(Fc') and IgG(H + L) than GVPs. However, prevention of carrier state in GVPs coincided with a significant increase of serum IgA when compared to BVPs. These results suggest that immunization with ghosts, that bias antibody populations specific to non-denaturated surface antigens, may be more efficacious in protecting pigs against colonization and infection than bacterins. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2945 / 2955
页数:11
相关论文
共 50 条
[1]   TOXICITY OF HEMOPHILUS-PLEUROPNEUMONIAE FOR PORCINE LUNG MACROPHAGES, PERIPHERAL-BLOOD MONOCYTES, AND TESTICULAR CELLS [J].
BENDIXEN, PH ;
SHEWEN, PE ;
ROSENDAL, S ;
WILKIE, BN .
INFECTION AND IMMUNITY, 1981, 33 (03) :673-676
[2]  
BICE DE, 1991, IMMUNOLOGY, V74, P215
[3]  
BOSSE JT, 1992, INFECT IMMUN, V60, P479
[4]   PULMONARY DISTRIBUTION OF PARTICLES GIVEN BY INTRATRACHEAL INSTILLATION OR BY AEROSOL INHALATION [J].
BRAIN, JD ;
KNUDSON, DE ;
SOROKIN, SP ;
DAVIS, MA .
ENVIRONMENTAL RESEARCH, 1976, 11 (01) :13-33
[5]  
BRANDTZAEG P, 1992, J INFECT DIS S1, V165, P167
[6]   ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) - MEASURE OF ANTIBODY CONCENTRATION OR AFFINITY [J].
BUTLER, JE ;
FELDBUSH, TL ;
MCGIVERN, PL ;
STEWART, N .
IMMUNOCHEMISTRY, 1978, 15 (02) :131-136
[7]   PROTECTIVE EFFICACY OF CONJUGATE VACCINES AGAINST EXPERIMENTAL CHALLENGE WITH PORCINE ACTINOBACILLUS-PLEUROPNEUMONIAE [J].
BYRD, W ;
HARMON, BG ;
KADIS, S .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 34 (3-4) :307-324
[8]   PREPARATION, CHARACTERIZATION, AND IMMUNOGENICITY OF CONJUGATE VACCINES DIRECTED AGAINST ACTINOBACILLUS-PLEUROPNEUMONIAE VIRULENCE DETERMINANTS [J].
BYRD, W ;
KADIS, S .
INFECTION AND IMMUNITY, 1992, 60 (08) :3042-3051
[9]   IMPROVED PROTECTION OF SWINE FROM PLEUROPNEUMONIA BY VACCINATION WITH PROTEINASE K-TREATED OUTER-MEMBRANE OF ACTINOBACILLUS (HAEMOPHILUS) PLEUROPNEUMONIAE [J].
CHIANG, YW ;
YOUNG, TF ;
RAPPGABRIELSON, VJ ;
ROSS, RF .
VETERINARY MICROBIOLOGY, 1991, 27 (01) :49-62
[10]   Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins [J].
Chiers, K ;
van Overbeke, I ;
De Laender, P ;
Ducatelle, R ;
Carel, S ;
Haesebrouck, F .
VETERINARY QUARTERLY, 1998, 20 (02) :65-69